Rett Syndrome > ANAVEX2-73 Oral Liquid

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome (EXCELLENCE Trial)

Recruiting in Palo Alto (17 mi)

+11 other locations

Age: < 18

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 2 & 3

Waitlist Available

Sponsor: Anavex Life Sciences Corp.

Prior Safety Data

Trial Summary

What is the purpose of this trial?

This trial tests a liquid medicine called ANAVEX2-73 for children aged 5-17 with Rett Syndrome. The medicine is designed to improve brain function by targeting specific pathways. The study will last several weeks, with an option to continue for several months.

Eligibility Criteria

Participant Groups

Group I: ANAVEX2-73 Active Experimental Treatment 1 Intervention

ANAVEX2-73 liquid oral solution

Group II: ANAVEX2-73 Placebo Placebo Group 1 Intervention

Placebo liquid oral solution

Find A Clinic Near You

Research locations nearby Select from list below to view details:

Holland Bloorview Kids Hospital Toronto, Canada

Alberta Children's Hospital Calgary, Canada

British Columbia Children's Hospital Vancouver, Canada

Children's Hospital LHSC London, Canada

Who is running the clinical trial?

Anavex Life Sciences Corp. Lead Sponsor

Anavex Australia Pty Ltd. Industry Sponsor

Anavex Germany GmbH Industry Sponsor

References